|
Lymphoid Neoplasia
Citations 191-200 of 299 total displayed.
|
Past content
(since Jan 2009):
|
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- Abdel Kareem Azab, Judith M. Runnels, Costas Pitsillides, Anne-Sophie Moreau, Feda Azab, Xavier Leleu, Xiaoying Jia, Renee Wright, Beatriz Ospina, Alicia L. Carlson, Clemens Alt, Nicholas Burwick, Aldo M. Roccaro, Hai T. Ngo, Mena Farag, Molly R. Melhem, Antonio Sacco, Nikhil C. Munshi, Teru Hideshima, Barrett J. Rollins, Kenneth C. Anderson, Andrew L. Kung, Charles P. Lin, and Irene M. Ghobrial
Blood 2009; 113: 4341-4351.
[Abstract]
[Full text]
[PDF]
Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas
- Hans-Peter Gerber, May Kung-Sutherland, Ivan Stone, Carol Morris-Tilden, Jamie Miyamoto, Renee McCormick, Stephen C. Alley, Nicole Okeley, Brad Hayes, Francisco J. Hernandez-Ilizaliturri, Charlotte F. McDonagh, Paul J. Carter, Dennis Benjamin, and Iqbal S. Grewal
Blood 2009; 113: 4352-4361.
[Abstract]
[Full text]
[PDF]
Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia
- Michal Stark, Chen Wichman, Irit Avivi, and Yehuda G. Assaraf
Blood 2009; 113: 4362-4369.
[Abstract]
[Full text]
[PDF]
PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation
- Pengrong Yan, Jing Fu, Zhaoxia Qu, Shirong Li, Takashi Tanaka, Michael J. Grusby, and Gutian Xiao
Blood 2009; 113: 4370-4380.
[Abstract]
[Full text]
[PDF]
Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL
- Wendy R. Gordon, Monideepa Roy, Didem Vardar-Ulu, Megan Garfinkel, Marc R. Mansour, Jon C. Aster, and Stephen C. Blacklow
Blood 2009; 113: 4381-4390.
[Abstract]
[Full text]
[PDF]
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia
- Aldo M. Roccaro, Antonio Sacco, Changzhong Chen, Judith Runnels, Xavier Leleu, Feda Azab, Abdel Kareem Azab, Xiaoying Jia, Hai T. Ngo, Molly R. Melhem, Nicholas Burwick, Lyuba Varticovski, Carl D. Novina, Barrett J. Rollins, Kenneth C. Anderson, and Irene M. Ghobrial
Blood 2009; 113: 4391-4402.
[Abstract]
[Full text]
[PDF]
Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia
- Meike Vogler, Michael Butterworth, Aneela Majid, Renata J. Walewska, Xiao-Ming Sun, Martin J. S. Dyer, and Gerald M. Cohen
Blood 2009; 113: 4403-4413.
[Abstract]
[Full text]
[PDF]
A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy
- Robert M. Sharkey, Oliver W. Press, and David M. Goldenberg
Blood 2009; 113: 3891-3895.
[Abstract]
[Full text]
[PDF]
CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
- Volkmar Boehme, Norbert Schmitz, Samira Zeynalova, Markus Loeffler, and Michael Pfreundschuh
Blood 2009; 113: 3896-3902.
[Abstract]
[Full text]
[PDF]
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study
- Vahid Asnafi, Agnès Buzyn, Sandrine Le Noir, Frédéric Baleydier, Arnauld Simon, Kheira Beldjord, Oumedaly Reman, Francis Witz, Thierry Fagot, Emmanuelle Tavernier, Pascal Turlure, Thibaut Leguay, Françoise Huguet, Jean-Paul Vernant, Francis Daniel, Marie-Christine Béné, Norbert Ifrah, Xavier Thomas, Hervé Dombret, and Elizabeth Macintyre
Blood 2009; 113: 3918-3924.
[Abstract]
[Full text]
[PDF]
|
|
